224 related articles for article (PubMed ID: 36856542)
21. Co-registration of MALDI-MSI and histology demonstrates gangliosides co-localize with amyloid beta plaques in Alzheimer's disease.
Ollen-Bittle N; Pejhan S; Pasternak SH; Keene CD; Zhang Q; Whitehead SN
Acta Neuropathol; 2024 Jun; 147(1):105. PubMed ID: 38896306
[TBL] [Abstract][Full Text] [Related]
22. High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain.
Güntert A; Döbeli H; Bohrmann B
Neuroscience; 2006 Dec; 143(2):461-75. PubMed ID: 17008022
[TBL] [Abstract][Full Text] [Related]
23. Phosphorylated Aβ peptides in human Down syndrome brain and different Alzheimer's-like mouse models.
Kumar S; Lemere CA; Walter J
Acta Neuropathol Commun; 2020 Jul; 8(1):118. PubMed ID: 32727580
[TBL] [Abstract][Full Text] [Related]
24.
Jean L; Brimijoin S; Vaux DJ
J Biol Chem; 2019 Apr; 294(16):6253-6272. PubMed ID: 30787102
[TBL] [Abstract][Full Text] [Related]
25. Human Alzheimer's disease gene expression signatures and immune profile in APP mouse models: a discrete transcriptomic view of Aβ plaque pathology.
Rothman SM; Tanis KQ; Gandhi P; Malkov V; Marcus J; Pearson M; Stevens R; Gilliland J; Ware C; Mahadomrongkul V; O'Loughlin E; Zeballos G; Smith R; Howell BJ; Klappenbach J; Kennedy M; Mirescu C
J Neuroinflammation; 2018 Sep; 15(1):256. PubMed ID: 30189875
[TBL] [Abstract][Full Text] [Related]
26. BACE1 elevation is involved in amyloid plaque development in the triple transgenic model of Alzheimer's disease: differential Aβ antibody labeling of early-onset axon terminal pathology.
Cai Y; Zhang XM; Macklin LN; Cai H; Luo XG; Oddo S; Laferla FM; Struble RG; Rose GM; Patrylo PR; Yan XX
Neurotox Res; 2012 Feb; 21(2):160-74. PubMed ID: 21725719
[TBL] [Abstract][Full Text] [Related]
27. Correlative Chemical Imaging and Spatial Chemometrics Delineate Alzheimer Plaque Heterogeneity at High Spatial Resolution.
Wehrli PM; Ge J; Michno W; Koutarapu S; Dreos A; Jha D; Zetterberg H; Blennow K; Hanrieder J
JACS Au; 2023 Mar; 3(3):762-774. PubMed ID: 37006756
[TBL] [Abstract][Full Text] [Related]
28. Pre-plaque conformational changes in Alzheimer's disease-linked Aβ and APP.
Klementieva O; Willén K; Martinsson I; Israelsson B; Engdahl A; Cladera J; Uvdal P; Gouras GK
Nat Commun; 2017 Mar; 8():14726. PubMed ID: 28287086
[TBL] [Abstract][Full Text] [Related]
29. Gd-nanoparticles functionalization with specific peptides for ß-amyloid plaques targeting.
Plissonneau M; Pansieri J; Heinrich-Balard L; Morfin JF; Stransky-Heilkron N; Rivory P; Mowat P; Dumoulin M; Cohen R; Allémann É; Tόth É; Saraiva MJ; Louis C; Tillement O; Forge V; Lux F; Marquette C
J Nanobiotechnology; 2016 Jul; 14(1):60. PubMed ID: 27455834
[TBL] [Abstract][Full Text] [Related]
30. Unlocking the Molecular Variations of a Micron-Scale Amyloid Plaque in an Early Stage Alzheimer's Disease by a Cellular-Resolution Mass Spectrometry Imaging Platform.
Lv Y; Yan S; Deng K; Chen Z; Yang Z; Li F; Luo Q
ACS Chem Neurosci; 2024 Jan; 15(2):337-345. PubMed ID: 38166448
[TBL] [Abstract][Full Text] [Related]
31. Following spatial Aβ aggregation dynamics in evolving Alzheimer's disease pathology by imaging stable isotope labeling kinetics.
Michno W; Stringer KM; Enzlein T; Passarelli MK; Escrig S; Vitanova K; Wood J; Blennow K; Zetterberg H; Meibom A; Hopf C; Edwards FA; Hanrieder J
Sci Adv; 2021 Jun; 7(25):. PubMed ID: 34134980
[TBL] [Abstract][Full Text] [Related]
32. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
Elife; 2020 Jun; 9():. PubMed ID: 32510331
[TBL] [Abstract][Full Text] [Related]
33. Characterization of IMPY as a potential imaging agent for beta-amyloid plaques in double transgenic PSAPP mice.
Kung MP; Hou C; Zhuang ZP; Cross AJ; Maier DL; Kung HF
Eur J Nucl Med Mol Imaging; 2004 Aug; 31(8):1136-45. PubMed ID: 15007564
[TBL] [Abstract][Full Text] [Related]
34. Development of novel 123I-labeled pyridyl benzofuran derivatives for SPECT imaging of β-amyloid plaques in Alzheimer's disease.
Ono M; Cheng Y; Kimura H; Watanabe H; Matsumura K; Yoshimura M; Iikuni S; Okamoto Y; Ihara M; Takahashi R; Saji H
PLoS One; 2013; 8(9):e74104. PubMed ID: 24058519
[TBL] [Abstract][Full Text] [Related]
35. The Effect of Spinal Cord Injury on Beta-Amyloid Plaque Pathology in TgCRND8 Mouse Model of Alzheimer's Disease.
Yuan Q; Yang J; Xian YF; Liu R; Chan CW; Wu W; Lin ZX
Curr Alzheimer Res; 2020; 17(6):576-586. PubMed ID: 32851942
[TBL] [Abstract][Full Text] [Related]
36. Identification of amyloid plaques in retinas from Alzheimer's patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model.
Koronyo-Hamaoui M; Koronyo Y; Ljubimov AV; Miller CA; Ko MK; Black KL; Schwartz M; Farkas DL
Neuroimage; 2011 Jan; 54 Suppl 1():S204-17. PubMed ID: 20550967
[TBL] [Abstract][Full Text] [Related]
37. Label-free vibrational imaging of different Aβ plaque types in Alzheimer's disease reveals sequential events in plaque development.
Röhr D; Boon BDC; Schuler M; Kremer K; Hoozemans JJM; Bouwman FH; El-Mashtoly SF; Nabers A; Großerueschkamp F; Rozemuller AJM; Gerwert K
Acta Neuropathol Commun; 2020 Dec; 8(1):222. PubMed ID: 33308303
[TBL] [Abstract][Full Text] [Related]
38. Chemical signatures delineate heterogeneous amyloid plaque populations across the Alzheimer's disease spectrum.
Koutarapu S; Ge J; Dulewicz M; Srikrishna M; Szadziewska A; Wood J; Blennow K; Zetterberg H; Michno W; Ryan NS; Lashley T; Savas J; Schöll M; Hanrieder J
bioRxiv; 2024 Jun; ():. PubMed ID: 38895368
[TBL] [Abstract][Full Text] [Related]
39. Comparative analysis of amyloid-beta chemical structure and amyloid plaque morphology of transgenic mouse and Alzheimer's disease brains.
Kuo YM; Kokjohn TA; Beach TG; Sue LI; Brune D; Lopez JC; Kalback WM; Abramowski D; Sturchler-Pierrat C; Staufenbiel M; Roher AE
J Biol Chem; 2001 Apr; 276(16):12991-8. PubMed ID: 11152675
[TBL] [Abstract][Full Text] [Related]
40. Engineering of donor-acceptor-donor curcumin analogues as near-infrared fluorescent probes for
Fang D; Wen X; Wang Y; Sun Y; An R; Zhou Y; Ye D; Liu H
Theranostics; 2022; 12(7):3178-3195. PubMed ID: 35547754
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
